Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)
Brazil · Delayed Price · Currency is BRL 12.90
-0.15 (-1.15%)
May 12, 2026, 5:07 PM GMT-3
BVMF:PNVL3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,703 | 5,512 | 4,942 | 4,461 | 3,990 | 3,225 | |
Revenue Growth (YoY) | 14.63% | 11.53% | 10.79% | 11.79% | 23.72% | 14.41% |
Cost of Revenue | 3,813 | 3,684 | 3,337 | 3,079 | 2,745 | 2,231 |
Gross Profit | 1,890 | 1,828 | 1,605 | 1,382 | 1,245 | 994.64 |
Selling, General & Admin | 1,583 | 1,548 | 1,395 | 1,210 | 1,099 | 907.41 |
Other Operating Expenses | 35.13 | 23.18 | 12.91 | 9.53 | 8 | -15.56 |
Operating Expenses | 1,618 | 1,571 | 1,408 | 1,220 | 1,107 | 891.85 |
Operating Income | 271.67 | 256.83 | 197.33 | 161.89 | 137.84 | 102.78 |
Interest Expense | -137.81 | -133.94 | -104.88 | -102.57 | -70.03 | -37.12 |
Interest & Investment Income | 41.27 | 41.27 | 30.99 | 34.39 | 18.18 | 16.63 |
Other Non Operating Income (Expenses) | -19.55 | -16.49 | -8.83 | -6.81 | -7.01 | 2.2 |
EBT Excluding Unusual Items | 155.58 | 147.68 | 114.62 | 86.9 | 78.99 | 84.49 |
Gain (Loss) on Sale of Assets | -3.53 | -3.53 | -4.03 | -2.26 | -2.07 | -2.74 |
Other Unusual Items | 1.4 | 1.4 | 1.97 | 6.95 | 1.51 | 1.49 |
Pretax Income | 153.44 | 145.54 | 112.56 | 91.58 | 78.43 | 83.24 |
Income Tax Expense | 21.07 | 20.94 | 7.06 | -1.32 | -7.92 | 3.81 |
Net Income | 132.37 | 124.61 | 105.51 | 92.91 | 86.35 | 79.43 |
Net Income to Common | 132.37 | 124.61 | 105.51 | 92.91 | 86.35 | 79.43 |
Net Income Growth | 35.87% | 18.10% | 13.57% | 7.60% | 8.71% | 41.45% |
Shares Outstanding (Basic) | 149 | 149 | 149 | 149 | 149 | 150 |
Shares Outstanding (Diluted) | 149 | 150 | 150 | 150 | 149 | 150 |
Shares Change (YoY) | -0.21% | -0.08% | 0.42% | 0.38% | -0.30% | -1.27% |
EPS (Basic) | 0.89 | 0.84 | 0.71 | 0.62 | 0.58 | 0.53 |
EPS (Diluted) | 0.89 | 0.83 | 0.70 | 0.62 | 0.58 | 0.53 |
EPS Growth | 36.54% | 18.57% | 12.90% | 6.90% | 9.24% | 43.27% |
Free Cash Flow | 332.55 | 350.95 | 101.73 | 182.2 | 56.18 | 21.13 |
Free Cash Flow Per Share | 2.24 | 2.34 | 0.68 | 1.22 | 0.38 | 0.14 |
Dividend Per Share | - | - | - | 0.252 | - | 0.175 |
Dividend Growth | - | - | - | - | - | 28.37% |
Gross Margin | 33.14% | 33.17% | 32.48% | 30.97% | 31.20% | 30.84% |
Operating Margin | 4.76% | 4.66% | 3.99% | 3.63% | 3.45% | 3.19% |
Profit Margin | 2.32% | 2.26% | 2.14% | 2.08% | 2.16% | 2.46% |
Free Cash Flow Margin | 5.83% | 6.37% | 2.06% | 4.08% | 1.41% | 0.66% |
EBITDA | 342.58 | 322.52 | 407.54 | 362.04 | 322.41 | 260.56 |
EBITDA Margin | 6.01% | 5.85% | 8.25% | 8.12% | 8.08% | 8.08% |
D&A For EBITDA | 70.91 | 65.69 | 210.2 | 200.15 | 184.57 | 157.77 |
EBIT | 271.67 | 256.83 | 197.33 | 161.89 | 137.84 | 102.78 |
EBIT Margin | 4.76% | 4.66% | 3.99% | 3.63% | 3.45% | 3.19% |
Effective Tax Rate | 13.73% | 14.38% | 6.27% | - | - | 4.58% |
Revenue as Reported | 5,703 | 5,512 | 4,942 | 4,461 | 3,990 | 3,225 |
Advertising Expenses | - | 40.42 | 33.16 | 29.34 | 26.21 | 19.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.